PremiumCompany AnnouncementsAstraZeneca Updates Total Voting Rights and Admits New Shares from Employee Schemes3d agoAZN
PremiumCompany AnnouncementsFDA panel’s negative vote clouds AstraZeneca’s bid for camizestrant in advanced breast cancer3d agoAZN